find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
34
Clinical Trials
Leukemia
Phase I
Accepting Patients
nct/study# NCT03915379 / JNJ-67571244-AML-1001
A Phase 1, First-In-Human, Dose Escalation Study Of JNJ-67571244 (Bispecific Antibody Targeting CD33 And CD3) In Subjects With Relapsed Or Refractory Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
Learn More
Leukemia
Phase I
Accepting Patients
nct/study# NCT04075747 / JZP025-101
V-FAST: A Phase 1b Master Trial To Investigate CPX-351 Combined With Various Targeted Agents In Subjects With Previously Untreated Acute Myeloid Leukemia
Learn More
Leukemia
Phase III
Accepting Patients
nct/study# NCT03589326 / PONATINIB-3001
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered In Combination With Reduced-Intensity Chemotherapy, In Patients With Actively Diagnosed Philadelphia Chromosome?Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Learn More
Leukemia
NA
Active
nct/study# NA / 19C-282
Vyxeos Outpatient Induction Therapy Without Subsequent Planned Admission: A Multicenter Analysis Of Safety And Medical Resource Utilization
Learn More
Leukemia
NA
Active
nct/study# NA / CPX351/VYXEOS
Phase IB/II Of CPX-351 As Maintenance Therapy In AML Patients Ineligible For Bone Marrow Transplantation
Learn More
Leukemia
Phase III
Active
nct/study# NA / KB-ENTO-3001
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.